Trial Profile
An open-label study of the effect of NeoRecormon on quality of life in patients with anemia who have multiple myeloma, low-grade non-Hodgkin's lymphoma, or chronic lymphocytic leukemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2010
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Roche
- 26 Feb 2010 New trial record